Reactivation of Developmentally Expressed p63 Isoforms Predisposes to Tumor Development and Progression
Open Access
- 15 April 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (8), 3981-3986
- https://doi.org/10.1158/0008-5472.can-06-0027
Abstract
Genes that are active during normal development are frequently reactivated during neoplastic transformation. We now report that developmentally expressed TAp63 isoforms are frequently reactivated in human squamous cell carcinomas. To determine the consequences of TAp63 reactivation, we induced TAp63α expression during chemically-induced skin carcinogenesis. Deregulated TAp63α expression dramatically accelerated tumor development and progression, frequently resulting in epithelial-mesenchymal transitions to spindle cell carcinomas and lung metastases. Consistent with this observation, we detected high levels of Twist and N-cadherin in tumors overexpressing TAp63α. Thus, as observed for other developmental pathways, aberrant reactivation of TAp63 predisposes to tumor development and progression. (Cancer Res 2006; 66(8): 3981-6)This publication has 19 references indexed in Scilit:
- p63: oncogene or tumor suppressor?Current Opinion in Genetics & Development, 2006
- p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivoOncogene, 2005
- Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 familyCancer Cell, 2005
- Differential Regulation of MDR1 Transcription by the p53 Family MembersPublished by Elsevier BV ,2005
- Overexpression of Transforming Growth Factor β1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial HyperproliferationCancer Research, 2004
- Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor MetastasisCell, 2004
- p63 is the molecular switch for initiation of an epithelial stratification programGenes & Development, 2004
- Multistage carcinogenesis in mouse skinPharmacology & Therapeutics, 1992
- Aberrant expression during two‐stage mouse skin carcinogenesis of a type 147‐kDa keratin, k13, normally associated with terminal differentiation of internal stratified epitheliaMolecular Carcinogenesis, 1988
- Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesisNature, 1986